PSI

   |   

   |   

   |   

   |   


Home PSI About Us Full Service Contract Research Organization (CRO) Global Reach On-Time Enrollment Therapeutic Excellence Contract Research Organization (CRO) News

Clinical Trial News     |     Social Media     |     PSI Newsletters     |     PSI Newsletter Articles

Contract Research Organization (CRO) News
You are here:   Home > News > Clinical Trial News
Email Page Print Page

Week 5

  • PSI completed a phase III study of a novel biological agent in patients with gout.
  • PSI completed a phase II study of a novel biological agent in patients with acute myeloid leukemia.
  • PSI completed the active treatment period in a phase II study of a novel biological agent in patients with Crohn’s disease.



About PSI Full Service CRO Global Reach On-Time Enrollment Therapeutic Excellence News
Full Name
Email
Details

© PSI, 1995-2012. All rights reserved. | Terms of Access | Disclaimer | Privacy Policy | Sitemap

PSI on Xing PSI on Twitter PSI on Facebook PSI on Linkedin News Archives